
    
      There were 2 phases in the study, a Dose Escalation phase (Phase 1b) and a Dose Expansion
      phase (Phase 2a). In the Dose Escalation phase, 3 patients were enrolled at the first dose
      level (3.0 mg/kg trastuzumab emtansine) and and 6 patients were enrolled at the second dose
      level (3.6 mg/kg trastuzumab emtansine). An additional 58 patients were enrolled at the 3.6
      mg/kg trastuzumab emtansine dose level in the Dose Expansion phase (Phase 2a) of the study.
    
  